References
- Bettigole R E, Himelstein E S, Oettgen H F, Chilliford G O. Hypofibrinogenemia due to L-asparaginase: Studies of fibrinogen survival using autologous I-fibrinogen. Blood 1970; 35: 194
- Buchanan G R, Holtkamp C A. Reduced antithrombin III levels during L-asparaginase therapy. Med Pediatr Oncol 1980; 8: 7
- Deutsch E, Fischer M, Frischauf H, Honetz N, Lechner K, Pesendorfer F, Stych H, Weismann A. Blood coagulation changes under L-asparaginase therapy. Recent Results in Cancer Research, E Grundemann, EF Oettgen. Springer-Verlag, New York 1970; Vol 33: 331
- Gadner H, Riehm H. Veränderungen der Hämostase während der Induktionstherapie akuter lymphoblastischer Leukämien im Kindesalter. Klin Paediatr (Buech Paediatr) 1977; 78: 130
- Pitney W R, Phadke K P, Dean S. Antithrombin III deficiency during asparaginase therapy. Lancet 1980; i: 493, (letter)
- Pralle H, Schöndorf TH, Graubner M. Antithrombin Ill-Mangel unter L-Asparaginase-Therapie. Haemostase, Thrombophilie und Arteriosklerose, J Van de Loo, F Asbeck. Schattauer, Stuttgart 1982; 348
- Priest J R, Ramsay N KC, Bennett A J, Krivit W, Edson J R. The effect of L-asparaginase on antithrombin, plasminogen and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr 1982; 100: 990
- Sills R H, Nelson D A, Stockmann JA, III. L-asparaginase coagulopathy during therapy for acute lymphocytic leukemia. Med Pediatr Oncol 1978; 4: 311
- Vellenga E, Mulder N H, Nieweg H O. Antithrombin III deficiency during asparaginase therapy. Lancet 1980; i: 649, (letter)
- Wada J K, Patch M J, McGehee W G. Low levels of anti-thrombin (AT-III) due to L-asparaginase (asp). Blood 1979; 54: 308a, (Suppl 1) (abstract)
- Ch Urban, Sager W D. Intracranial bleeding during therapy with L-asparaginase in childhood acute lymphocytic leukemia. Eur J Pediatr 1981; 137: 323
- Cairo M S, Lazarus K, Gilmore R L, Bachner R L. Intracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia. J Pediatr 1980; 97: 829
- Conrad J, Cazenave B, Maury J, Horellou M H, Samama M. L-asparaginase, antithrombin III, and thrombosis. Lancet 1980; i: 1091, (letter)
- Priest J R, Ramsay N KC, Steinherz P G, Tubergen D G, Cairo M S, Sitarz A, Bishop A, White L, Trigg M E, Levitt C J, Cich J A, Coccia P F. A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia. J Pediatr 1982; 100: 984
- Riehm H J, Gadner H, Henze G, Langermann H J, Odenwald E. The Berlin childhood acute lymphoblastic leukemia therapy study, 1970–1976. Am J Pediatr Hematol/Oncol 1980; 2: 299
- Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237
- Capizzi R L, Bertino JR, Skeel R T, Creasey W A, Zanes R, Olayon C, Peterson R G, Handschumacher R E. L-asparaginase: Clinical, biochemical, pharmacological, and immunological studies. Ann Intern Med 1971; 74: 893
- Shapiro R, Kim Y, Michael A F, Gerrard J M, Nesbit M E, Coccia P F, Ramsay N KC, Krivit W. L-asparaginase induced hypocomplementemia in acute lymphocytic leukemia. Am J Pediatr Hematol/Oncol 1979; 1: 5
- Komp D M, Lyles R L, Boyd TH, III, Stoner G E, Cox B J. The effect of cancer chemotherapeutic agents of fibrin formation and stabilization in vitro. Pediatr Res 1974; 8: 75
- Nagasawa H, Kim B K, Steiner M, Baldini M G. Inhibition of thrombin-neutralizing activity of antithrombin III by steroid hormones. Thromb Haemostas 1982; 47: 157
- Andrassy K, Ritz E, Sonwald R. Australia-Antigen-Nachweis in fibrinogenkonzentraten und anderen gerinnungsaktiven Proteinen. Dtsch Med Wochenschr 1970; 95: 2467